Altered prostaglandin (PG) function, specifically a deficiency in PGE1 and thromboxane A2 (TxA2) with excess PGE2, may drive autoimmune diseases. Treatments enhancing TxA2 and PGE1 show promise in managing these conditions.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: